ADVFN - Advanced Financial Network.
HOME» NASDAQ » C » CYBX Stock Price » CYBX Stock News

Cyberonics Share News

 Cyberonics (mm) Stock Price
CYBX Stock Price
 Cyberonics (mm) Stock Chart
CYBX Stock Chart
 Cyberonics (mm) Stock News
CYBX Stock News
 Cyberonics (mm) Company Information
CYBX Company Information
 Cyberonics (mm) Stock Trades
CYBX Stock Trades

Cyberonics 2Q Net Down 50% On Lower Tax Benefit; View Raised

DOW JONES NEWSWIRES Cyberonics Inc.'s (CYBX) fiscal second-quarter earnings fell 50% as the medical-device company was hurt by a lower tax benefit, masking higher-than-expected revenue growth and a stronger margin on price increases and higher production. For the year, the company raised its operating income forecast by $3 million to $45 million to $48 million and lifted its revenue view to $187 million to $190 million from its increased August outlook of $184 million to $188 million. The maker of implantable pacemakerlike devices that treat drug-resistant epilepsy has been trying to expand into depression treatment and is exploring ways for its devices to detect and potentially respond better to seizures. But it faces possible competition from the larger Medtronic Inc. (MDT) and privately held NeuroPace Inc. For the quarter ended Oct. 29, Cyberonics reported a profit of $24.9 million, or 88 cents a share, down from $50.1 million, or $1.73 a share, a year earlier. Excluding tax benefits, earnings fell to 25 cents from 33 cents while net sales jumped to $47.5 million from $40.7 million. Analysts polled by Thomson Reuters most recently forecast earnings of 25 cents a share on revenue of $46 million. Operating margin rose to 26.9% from 22.3% on the price increases. U.S. sales, the vast majority of Cyberonics's business, grew 20%. International sales were up 3%, or double that excluding currency fluctuations. The U.S. epilepsy business saw 14% unit growth, and global epilepsy sales grew more than 15% for the 12th straight quarter. Shares closed Friday at $27.20 and were inactive premarket. The stock is up by a third this year. -By Tess Stynes, Dow Jones Newswires; 212-416-2481;;

Stock News for Cyberonics (CYBX)
10/09/201511:00:00Sorin And Cyberonics Announce Appointment Of Remaining Post-Merger...
10/05/201519:25:00Cyberonics Set to Join the S&P MidCap 400; Ruckus Wireless to...
10/02/201508:48:39Statement of Changes in Beneficial Ownership (4)
10/02/201508:46:12Statement of Changes in Beneficial Ownership (4)
10/02/201508:43:54Statement of Changes in Beneficial Ownership (4)
09/28/201508:00:00Extended Follow-Up Of ANTHEM-HF Patients Shows That Benefits...
09/23/201510:00:00High Court Of England And Wales Issues Order Approving Completion...
09/22/201517:24:44Current Report Filing (8-k)
09/22/201517:00:00Cyberonics Stockholders Overwhelmingly Approve Merger With Sorin
09/18/201515:55:58Statement of Changes in Beneficial Ownership (4)
09/10/201517:18:37Filing of Certain Prospectuses and Communications in Connection...
09/10/201517:17:42Filing of Certain Prospectuses and Communications in Connection...
09/10/201516:10:54Current Report Filing (8-k)
09/10/201516:09:09Filing of Certain Prospectuses and Communications in Connection...
09/10/201512:15:00Sorin and Cyberonics Announce Appointment of LivaNova’s Chief F...
09/10/201512:00:00Sorin And Cyberonics Announce Appointment Of LivaNova's Chief...
09/09/201514:53:36Statement of Changes in Beneficial Ownership (4)
09/09/201509:24:49Current Report Filing (8-k)
09/09/201509:22:49Filing of Certain Prospectuses and Communications in Connection...

Cyberonics and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations